Monday, September 1, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

Light Therapy Prevents Chemo Mouth Sores in Kids

May 3, 2025
in Cancer
Reading Time: 3 mins read
0
65
SHARES
594
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a groundbreaking study poised to revolutionize supportive cancer care in pediatric hematology, researchers have unveiled compelling evidence supporting the use of photobiomodulation (PBM) and photodynamic therapy (PDT) to prevent and treat chemotherapy-induced oral mucositis (OM). This debilitating condition, a frequent complication of chemotherapy protocols such as methotrexate (MTX) administration, inflicts painful ulcerations in the oral mucosa, profoundly impairing quality of life, nutrition, and treatment adherence for young patients battling hematologic malignancies.

The study, conducted as a dual-arm randomized clinical trial, addressed a critical gap in pediatric oncology by exploring non-pharmacologic interventions capable of both halting the onset of OM and expediting its resolution when lesions emerge. PBM, a form of low-level laser therapy, employs precise wavelengths of light to modulate cellular metabolism, mitigate inflammatory processes, and promote tissue repair. Complementing this approach, PDT was investigated using indocyanine green (ICG) dye activated by low-level laser, harnessing photochemical reactions to target and ameliorate affected oral tissues.

In the prevention arm of the clinical trial, an innovative intra-patient design was utilized, whereby patients initially undergoing chemotherapy without laser intervention constituted control cycles and subsequently experienced PBM during ensuing cycles. This within-subject comparison under uniform chemotherapy regimens yielded striking findings: the incidence of oral mucositis plummeted dramatically from two-thirds of cycles (66.67%) without intervention to a mere 6.67% with PBM application.

The therapeutic arm focused on children who had already developed OM, randomizing participants to receive either sham laser treatment or PDT using ICG combined with low-level laser exposure. Evaluation metrics spanned recognized clinical scales—including the World Health Organization (WHO) mucositis scale, the National Cancer Institute (NCI) grading, and the WCCNR assessment—to quantify lesion severity and healing progression. Results demonstrated statistically significant improvements in the PDT group at both three and five days after treatment initiation, encompassing reductions across all scoring systems relative to controls.

Notably, the NCI score exhibited more pronounced declines between days three and five post-treatment in the PDT cohort, suggesting accelerated mucosal healing kinetics potentially attributable to the photodynamic mechanism. This rapid amelioration is particularly salient in the pediatric context, where minimizing mucositis duration can translate into reduced analgesic requirements, enhanced nutritional intake, diminished infection risk, and uninterrupted chemotherapy dosing schedules.

Underlying the observed clinical benefits, photobiomodulation’s mechanism involves low-power laser light stimulating mitochondrial cytochrome c oxidase, fostering ATP synthesis, and activating transcription factors that upregulate growth factors conducive to epithelial regeneration. Additionally, PBM modulates inflammatory cytokines, attenuates oxidative stress, and enhances microcirculatory dynamics within mucosal tissues, collectively laying a biological foundation for mucositis prophylaxis.

In parallel, PDT leverages the photosensitizing properties of ICG, which upon laser activation generates reactive oxygen species that selectively disrupt pathological cellular elements and modulate local immune responses. This photon-activated cytotoxicity may accelerate lesion clearance and confine inflammatory damage, marking a sophisticated adjunct or alternative to conventional mucositis management strategies.

From a clinical translational perspective, these findings resonate powerfully with the urgent need to integrate low-risk, non-invasive interventions into pediatric oncology supportive care. Oral mucositis not only prolongs hospitalization and inflates healthcare costs but also undermines psychological well-being in vulnerable children. The data suggesting that PBM and PDT markedly diminish OM incidence and severity could prompt rapid adoption in hematology-oncology units worldwide.

Importantly, safety profiles reported in the trial were favorable, with no significant adverse effects attributable to either PBM or PDT observed, underscoring their tolerability in a pediatric cohort often sensitive to treatment-related toxicities. The laser parameters and ICG dosing were meticulously standardized, ensuring reproducibility and paving the way for broader multicenter trials and eventual clinical guidelines formulation.

Looking forward, the implications of this research extend beyond methotrexate-induced OM, potentially informing management of mucositis arising from other cytotoxic agents or radiation therapy. Furthermore, the synergistic potential of combining PBM and PDT warrants exploration, as well as the optimization of dosing schedules and laser parameters tailored to patient-specific factors.

The trial’s robust design, featuring intra-patient controls and randomization, lends credence to the validity of the conclusions while addressing confounders such as inter-patient variability and chemotherapy regimen consistency. Registration with an official clinical trial registry enhances transparency and facilitates future systematic reviews and meta-analyses.

In conclusion, this innovative investigation offers a beacon of hope for alleviating one of pediatric oncology’s most arduous side effects. By harnessing the subtle power of light-based therapies, clinicians may soon possess effective tools to prevent and treat chemotherapy-induced oral mucositis, safeguarding the welfare and resilience of children courageously fighting hematologic cancers.

Subject of Research: Photobiomodulation and photodynamic therapy for prevention and treatment of chemotherapy-induced oral mucositis in pediatric hematologic cancer patients

Article Title: Efficacy of photobiomodulation for the prevention and treatment of chemotherapy-induced oral mucositis in pediatric patients with hematologic cancers: a randomized clinical trial

Article References: Lavaee, F., Rezazadeh, F., Amanati, A. et al. Efficacy of photobiomodulation for the prevention and treatment of chemotherapy-induced oral mucositis in pediatric patients with hematologic cancers: a randomized clinical trial. BMC Cancer 25, 825 (2025). https://doi.org/10.1186/s12885-025-14213-w

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14213-w

Tags: chemotherapy-induced oral mucositis treatmentclinical trial on light therapy for kidsimpact of oral mucositis on quality of lifeinnovative cancer treatment approachesintra-patient design in clinical trialslight therapy for chemotherapy-induced mouth soreslow-level laser therapy for oral ulcersnon-pharmacologic interventions for cancer carepediatric hematology supportive carephotobiomodulation in pediatric oncologyphotodynamic therapy for oral mucositispreventing chemotherapy complications in children
Share26Tweet16
Previous Post

Assessing Hunger Measurement Amid Gaza’s Starvation Crisis

Next Post

Rare PTPRB Mutation Linked to Eye and Vein Diseases

Related Posts

blank
Cancer

New Study Highlights Global Disparities in Cancer Research Funding

September 1, 2025
blank
Cancer

Tailored Risk Messages Show No Impact on Increasing Colorectal Cancer Screening Rates

September 1, 2025
blank
Cancer

Evaluating Diffuse Large B-Cell Lymphoma in Chinese Youth

September 1, 2025
blank
Cancer

DNA-Wrapped Nanoparticles Triple CRISPR’s Efficiency

September 1, 2025
blank
Cancer

Targeting Nrf2 in AML: Combating Chemoresistance

September 1, 2025
blank
Cancer

BH3 Mimetics Revolutionize Acute Myeloid Leukemia Treatment

September 1, 2025
Next Post
blank

Rare PTPRB Mutation Linked to Eye and Vein Diseases

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27543 shares
    Share 11014 Tweet 6884
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    957 shares
    Share 383 Tweet 239
  • Bee body mass, pathogens and local climate influence heat tolerance

    642 shares
    Share 257 Tweet 161
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    509 shares
    Share 204 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    313 shares
    Share 125 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • New Insights: Titanium Isotopes Reveal Mantle Redox Changes
  • Guiding New Early Childhood Scholars in Publishing
  • Building Bonds: Community Partnerships in Hospital Care
  • SUGT1 Boosts Serous Ovarian Cancer via FH Downregulation

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,182 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading